196 related articles for article (PubMed ID: 37968581)
21. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
Menon BK; Buck BH; Singh N; Deschaintre Y; Almekhlafi MA; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar J; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra S; Gioia LC; Jalini S; Cayer C; Phillips S; Elamin E; Shoamanesh A; Subramaniam S; Kate M; Jacquin G; Camden MC; Benali F; Alhabli I; Bala F; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe A; Sehgal A; Zhang Q; Lethebe BC; Doram C; Ademola A; Shamy M; Kenney C; Sajobi TT; Swartz RH;
Lancet; 2022 Jul; 400(10347):161-169. PubMed ID: 35779553
[TBL] [Abstract][Full Text] [Related]
22. Intravenous Tissue Plasminogen Activator in Stroke Mimics.
Ali-Ahmed F; Federspiel JJ; Liang L; Xu H; Sevilis T; Hernandez AF; Kosinski AS; Prvu Bettger J; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC; Peterson ED; Xian Y
Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005609. PubMed ID: 31412730
[TBL] [Abstract][Full Text] [Related]
23. Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke.
Tsivgoulis G; Katsanos AH; Christogiannis C; Faouzi B; Mavridis D; Dixit AK; Palaiodimou L; Khurana D; Petruzzellis M; Psychogios K; Macleod MJ; Ahmed N
Ann Neurol; 2022 Sep; 92(3):349-357. PubMed ID: 35713213
[TBL] [Abstract][Full Text] [Related]
24. The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke.
Logallo N; Kvistad CE; Nacu A; Naess H; Waje-Andreassen U; Asmuss J; Aamodt AH; Lund C; Kurz MW; Rønning OM; Salvesen R; Idicula TT; Thomassen L
BMC Neurol; 2014 May; 14():106. PubMed ID: 24886064
[TBL] [Abstract][Full Text] [Related]
25. Tenecteplase Versus Alteplase for Acute Stroke: Mortality and Bleeding Complications.
Murphy LR; Hill TP; Paul K; Talbott M; Golovko G; Shaltoni H; Jehle D
Ann Emerg Med; 2023 Dec; 82(6):720-728. PubMed ID: 37178103
[TBL] [Abstract][Full Text] [Related]
26. Conversion From Intravenous Alteplase to Tenecteplase for Treatment of Acute Ischemic Stroke Across a Large Community Hospital Health System.
Dittmar E; Wolfel T; Menendez L; Pozo J; Ramirez M; Belnap SC; De Los Rios La Rosa F
Ann Pharmacother; 2023 Oct; 57(10):1147-1153. PubMed ID: 36688289
[TBL] [Abstract][Full Text] [Related]
27. Major Bleeding Postadministration of Tenecteplase Versus Alteplase in Acute Ischemic Stroke.
Walton MN; Hamilton LA; Salyer S; Wiseman BF; Forster AM; Rowe AS
Ann Pharmacother; 2023 May; 57(5):535-543. PubMed ID: 36004394
[TBL] [Abstract][Full Text] [Related]
28. Evolving Thrombolytics: from Alteplase to Tenecteplase.
Miller SE; Warach SJ
Neurotherapeutics; 2023 Apr; 20(3):664-678. PubMed ID: 37273127
[TBL] [Abstract][Full Text] [Related]
29. Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial.
Bivard A; Zhao H; Churilov L; Campbell BCV; Coote S; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski AH; Dos Santos A; Ng JL; Yogendrakumar V; Ng F; Langenberg F; Easton D; Warwick A; Mackey E; MacDonald A; Sharma G; Stephenson M; Smith K; Anderson D; Choi P; Thijs V; Ma H; Cloud GC; Wijeratne T; Olenko L; Italiano D; Davis SM; Donnan GA; Parsons MW;
Lancet Neurol; 2022 Jun; 21(6):520-527. PubMed ID: 35525251
[TBL] [Abstract][Full Text] [Related]
30. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials.
Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z
Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis.
Wei H; Fu B; Yang C; Huang M
Neurol Sci; 2023 Sep; 44(9):3005-3015. PubMed ID: 37061572
[TBL] [Abstract][Full Text] [Related]
32. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
[TBL] [Abstract][Full Text] [Related]
33. Tenecteplase Versus Alteplase Between 3 and 4.5 Hours in Low National Institutes of Health Stroke Scale.
Rønning OM; Logallo N; Thommessen B; Tobro H; Novotny V; Kvistad CE; Aamodt AH; Næss H; Waje-Andreassen U; Thomassen L
Stroke; 2019 Feb; 50(2):498-500. PubMed ID: 30602354
[TBL] [Abstract][Full Text] [Related]
34. Comparison of thrombolytic agents in treatment of patients with acute ischemic stroke; findings from a single centre follow up study in real-life settings.
George M; Baby N; Paul R; Zabeer M; Thomas C
J Clin Neurosci; 2021 Sep; 91():299-305. PubMed ID: 34373043
[TBL] [Abstract][Full Text] [Related]
35. Complications of Intravenous Tenecteplase Versus Alteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Rose D; Cavalier A; Kam W; Cantrell S; Lusk J; Schrag M; Yaghi S; Stretz C; de Havenon A; Saldanha IJ; Wu TY; Ranta A; Barber PA; Marriott E; Feng W; Kosinski AS; Laskowitz D; Poli S; Mac Grory B
Stroke; 2023 May; 54(5):1192-1204. PubMed ID: 36951049
[TBL] [Abstract][Full Text] [Related]
36. Tenecteplase, 0.4 mg/kg, in Moderate and Severe Acute Ischemic Stroke: A Pooled Analysis of NOR-TEST and NOR-TEST 2A.
Novotny V; Kvistad CE; Naess H; Logallo N; Fromm A; Khanevski AN; Thomassen L
J Am Heart Assoc; 2023 Oct; 12(20):e030320. PubMed ID: 37830342
[TBL] [Abstract][Full Text] [Related]
37. Tenecteplase vs. alteplase for the treatment of patients with acute ischemic stroke: a systematic review and meta-analysis.
Ma P; Zhang Y; Chang L; Li X; Diao Y; Chang H; Hui L
J Neurol; 2022 Oct; 269(10):5262-5271. PubMed ID: 35776193
[TBL] [Abstract][Full Text] [Related]
38. Tenecteplase use in the management of acute ischemic stroke: Literature review and clinical considerations.
Hailu K; Cannon C; Hayes S
Am J Health Syst Pharm; 2022 Jun; 79(12):944-949. PubMed ID: 35020806
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
Wang L; Hao M; Wu N; Wu S; Fisher M; Xiong Y
J Am Heart Assoc; 2024 May; 13(9):e031692. PubMed ID: 38686848
[TBL] [Abstract][Full Text] [Related]
40. Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial.
Sajobi TT; Arimoro OI; Ademola A; Singh N; Bala F; Almekhlafi MA; Deschaintre Y; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz GJ; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JS; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra SM; Gioia LC; Jalini S; Cayer C; Phillips SJ; Elamin E; Shoamanesh A; Subramaniam S; Kate MP; Jacquin G; Camden MC; Benali F; Alhabli I; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe AY; Sehgal A; Zhang Q; Lethebe B; Doram C; Shamy M; Kenney C; Buck BH; Swartz RH; Menon BK
Stroke; 2024 Mar; 55(3):524-531. PubMed ID: 38275116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
